The University of Texas-Houston (UTH) Medical School and collaborating clinical and basic investigators at the UTH-M.D. Anderson Cancer Center and the UTH-School of Public Health (Human Genetics Center) propose the renewal of the Specialized Center of Research (SCOR) in Scleroderma (systematic sclerosis or SSC) or UTH-SCOR- SSc. The Director of UTH-SCOR-SSc will be Frank C. Arnett, M.D. and the Co-Directors Benoit de Crombrugghe, M.D. (for basic research) and no effective treatment characterized by diffuse cutaneous and visceral fibrosis. The pathogenesis of SSc is unknown, no effective treatment characterized by diffuse cutaneous and visceral fibrosis. The pathogenesis of SSc is unknown, however, there is evidence for both genetic and environmental influences. Thus, the central theme of UTH- SCOR-SSc is the use of molecular approaches to understanding pathogenetic mechanisms, especially genetic factors, and the predictors of outcomes in SSC. Three interacting clinical and basic research project and two cores are proposed, as follows: 1) A human gebine0wide scan for SSc-associated genes using microsatellites (currently in progress) followed by genetic fine mapping using single nucleotide polymorphisms (SNP) in a unique Native American population with high disease prevalence; as well as in a well characterized, multi-ethnic cohort of SSc patients. Also, gene expression profiles in SSc fibroblasts and other tissues will be determined in the context of known metabolism and biochemical pathway using cDNA microarrays in order to better understanding molecular pathogenesis of SSc and to identify candidate genes for disease susceptibility and expression; 2) basic investigations in transgenic murine models of fibrosis, including microarray analyses of fibroblasts to compare with the human studies; 3) a large study of potential demographic, clinical, autoantibody and genetic predictors (including microarrays of SSC fibroblasts and other tissues) of disease outcomes in three ethnic groups (Caucasians, African-Americans and Mexican-Americans); 4) a Tissue Culture Core to process and store fibroblasts from SSC patients for the projects proposed; and 5) an Administrative and Biostatistical Core for administering UTH-SCOR- SSC and providing data management and biostatistical analysis for the projects proposed. The studies proposed here will provide better understanding of both the fundamental pathogenetic mechanisms and potentially useful clinical predictors of outcome in SSc which will lead to more directed therapies and/or disease prevention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center (P50)
Project #
5P50AR044888-09
Application #
6949676
Study Section
Special Emphasis Panel (ZAR1-AAA-B (M1))
Program Officer
Tyree, Bernadette
Project Start
1997-09-15
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2007-08-31
Support Year
9
Fiscal Year
2005
Total Cost
$1,097,677
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
McNearney, Terry A; Sallam, Hanaa S; Hunnicutt, Sonya E et al. (2013) Prolonged treatment with transcutaneous electrical nerve stimulation (TENS) modulates neuro-gastric motility and plasma levels of vasoactive intestinal peptide (VIP), motilin and interleukin-6 (IL-6) in systemic sclerosis. Clin Exp Rheumatol 31:140-50
Cockrill, Tonya; del Junco, Deborah J; Arnett, Frank C et al. (2010) Separate influences of birth order and gravidity/parity on the development of systemic sclerosis. Arthritis Care Res (Hoboken) 62:418-24
McNearney, Terry A; Sluka, K A; Ahn, C et al. (2010) Plasma endogenous enkephalin levels in early systemic sclerosis: clinical and laboratory associations. Clin Exp Rheumatol 28:S7-11
Sonnylal, Sonali; Shi-Wen, Xu; Leoni, Patricia et al. (2010) Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum 62:1523-32
McNearney, Terry A; Hunnicutt, Sonya E; Fischbach, Michael et al. (2009) Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine. J Rheumatol 36:2724-32
McNearney, T A; Sallam, H S; Hunnicutt, S E et al. (2009) Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients. Neurogastroenterol Motil 21:1269-e120
Assassi, Shervin; Del Junco, Deborah; Sutter, Kari et al. (2009) Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 61:1403-11
Hunnicutt, Sonya E; Grady, James; McNearney, Terry A (2008) Complementary and alternative medicine use was associated with higher perceived physical and mental functioning in early systemic sclerosis. Explore (NY) 4:259-63
Assassi, Shervin; Arnett, Frank C; Reveille, John D et al. (2007) Clinical, immunologic, and genetic features of familial systemic sclerosis. Arthritis Rheum 56:2031-7
Zhao, Jinying; Boerwinkle, Eric; Xiong, Momiao (2007) An entropy-based genome-wide transmission/disequilibrium test. Hum Genet 121:357-67

Showing the most recent 10 out of 53 publications